BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27941318)

  • 1. Early Detection of Desiccation and Curettage Failure in the Treatment of Basal Cell Carcinoma.
    Woldow AB; Melvin ME
    Dermatology; 2016; 232(6):696-699. PubMed ID: 27941318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does inflammation contribute to the eradication of basal cell carcinoma following curettage and electrodesiccation?
    Spencer JM; Tannenbaum A; Sloan L; Amonette RA
    Dermatol Surg; 1997 Aug; 23(8):625-30; discussion 630-1. PubMed ID: 9256908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological and immunohistochemical evaluation of basal cell carcinoma following curettage and electrodessication.
    Filho LL; de Oliveira de Avelar Alchorne A; Pereira GC; Lopes LR; de Carvalho TC
    Int J Dermatol; 2008 Jun; 47(6):610-4. PubMed ID: 18477158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation.
    Rodriguez-Vigil T; Vázquez-López F; Perez-Oliva N
    J Am Acad Dermatol; 2007 Jan; 56(1):91-5. PubMed ID: 17190625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrence rates of aggressive histologic types of basal cell carcinoma after treatment with electrodesiccation and curettage alone.
    Blixt E; Nelsen D; Stratman E
    Dermatol Surg; 2013 May; 39(5):719-25. PubMed ID: 23379543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryosurgery and curettage-cryosurgery for basal cell carcinomas of the mid-face.
    Samain A; Boullié MC; Duval-Modeste AB; Joly P
    J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1291-6. PubMed ID: 25354233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curettage-electrodesiccation treatment of basal cell carcinomas.
    Kopf AW; Bart RS; Schrager D; Lazar M; Popkin GL
    Arch Dermatol; 1977 Apr; 113(4):439-43. PubMed ID: 848972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal cell carcinoma margin delineation: is curettage useful? A surgical and histological study.
    Dika E; Fanti PA; Ismaili A; Misciali C; Vaccari S; Barisani A; Patrizi A
    J Dermatolog Treat; 2013 Jun; 24(3):238-42. PubMed ID: 23216407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical excision versus curettage plus cryosurgery in the treatment of basal cell carcinoma.
    Kuijpers DI; Thissen MR; Berretty PJ; Ideler FH; Nelemans PJ; Neumann MH
    Dermatol Surg; 2007 May; 33(5):579-87. PubMed ID: 17451581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based review of the use of cryosurgery in treatment of basal cell carcinoma.
    Kokoszka A; Scheinfeld N
    Dermatol Surg; 2003 Jun; 29(6):566-71. PubMed ID: 12786697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical excision of basal cell carcinoma with complete margin control: outcome at 5-year follow-up.
    Wetzig T; Woitek M; Eichhorn K; Simon JC; Paasch U
    Dermatology; 2010; 220(4):363-9. PubMed ID: 20484877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does wound healing contribute to the eradication of basal cell carcinoma following curettage and electrodessication?
    Nouri K; Spencer JM; Taylor JR; Hayag M; DeVoursney J; Shah N
    Dermatol Surg; 1999 Mar; 25(3):183-7; discussion 187-8. PubMed ID: 10193964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curettage and cautery of skin conditions.
    Crouch E
    Br J Gen Pract; 1992 Sep; 42(362):398. PubMed ID: 1457183
    [No Abstract]   [Full Text] [Related]  

  • 14. Follow-up of basal cell carcinomas: an audit of current practice.
    Mc Loone NM; Tolland J; Walsh M; Dolan OM
    J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):698-701. PubMed ID: 16836498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical therapy for basal cell epitheliomas by curettage only.
    McDaniel WE
    Arch Dermatol; 1978 Oct; 114(10):1491-2. PubMed ID: 718185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A challenging case of multiply recurrent nasal basal cell carcinoma.
    Mohammed F; Solish N; Murray CA
    J Cutan Med Surg; 2011; 15(5):285-9. PubMed ID: 21962189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multivariate risk score for recurrence of cutaneous basal cell carcinomas.
    Dubin N; Kopf AW
    Arch Dermatol; 1983 May; 119(5):373-7. PubMed ID: 6847215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of curettage and electrodesiccation in the removal of basal cell carcinoma.
    Edens BL; Bartlow GA; Haghighi P; Astarita RW; Davidson TM
    J Am Acad Dermatol; 1983 Sep; 9(3):383-8. PubMed ID: 6630599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and limitations of reflectance confocal microscopy in detecting persistence of basal cell carcinomas: a preliminary study.
    Webber SA; Wurm EM; Douglas NC; Lambie D; Longo C; Pellacani G; Soyer HP
    Australas J Dermatol; 2011 Aug; 52(3):179-85. PubMed ID: 21834812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: a randomized controlled trial with at least 5-year follow-up.
    Roozeboom MH; Aardoom MA; Nelemans PJ; Thissen MR; Kelleners-Smeets NW; Kuijpers DI; Mosterd K
    J Am Acad Dermatol; 2013 Aug; 69(2):280-7. PubMed ID: 23566914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.